Evaluation of Dalbavancin and Oritavancin as Cost-Effective Treatments of Acute Bacterial Skin and Skin Structure Infections in Hospitalized Patients

BACKGROUND: Acute bacterial skin and skin structure infections (ABSSSI) are a challenging medical problem associated with high health care costs. Dalbavancin and oritavancin are approved for treatment of ABSSSI and, due to their long half-life, are dosed as a one-time infusion. These agents may make...

Descripción completa

Detalles Bibliográficos
Autores principales: Koutsari, Christina, Gens, Krista, Holt, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631714/
http://dx.doi.org/10.1093/ofid/ofx163.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631714/
http://dx.doi.org/10.1093/ofid/ofx163.119

Ejemplares similares